Bill
Bill > HR3253
US HR3253
Empowering Beneficiaries, Ensuring Access, and Strengthening Accountability Act of 2019
summary
Introduced
06/13/2019
06/13/2019
In Committee
06/13/2019
06/13/2019
Crossed Over
06/19/2019
06/19/2019
Passed
08/01/2019
08/01/2019
Dead
Signed/Enacted/Adopted
08/06/2019
08/06/2019
Introduced Session
116th Congress
Bill Summary
Empowering Beneficiaries, Ensuring Access, and Strengthening Accountability Act of 2019 Empowering Beneficiaries, Ensuring Access, and Strengthening Accountability Act of 2019 This bill extends several health care programs and requirements and revises certain Medicare drug payment methodologies. (Sec. 2) The bill temporarily extends the Medicaid demonstration program for certified community behavioral health clinics. (Sec. 3) The bill also temporarily extends the applicability of Medicaid eligibility criteria that protect against spousal impoverishment for recipients of home- and community-based services. (Sec. 4) The bill increases appropriations for FY2019 for the Money Follows the Person Rebalancing Demonstration Program. (Under this program, the Centers for Medicare & Medicaid Services (CMS) may award grants to state Medicaid programs to assist states in increasing the use of home and community care for long-term care and decreasing the use of institutional care.) (Sec. 5) Additionally, the bill extends the Family-to-Family Health Information Centers Program, which is administered by the Health Resources and Services Administration. The program awards grants to family-run organizations to support the provision of information and peer support to families of children with special health care needs. (Sec. 6) Finally, the bill provides statutory authority for a Medicare payment methodology that applies an add-on payment of up to 3% for new drugs or biologics (furnished on or after January 1, 2019) when the average sales price is unavailable and payment is instead based on the wholesale acquisition cost (WAC). (Effective January 1, 2019, the CMS reduced the WAC add-on payment in such situations from 6% to 3%.)
AI Summary
This bill extends several health care programs and revises certain Medicare drug payment methodologies. It temporarily extends the Medicaid demonstration program for certified community behavioral health clinics, the Medicaid eligibility criteria that protect against spousal impoverishment for home- and community-based services recipients, and the appropriations for the Money Follows the Person Rebalancing Demonstration Program. Additionally, the bill extends the Family-to-Family Health Information Centers Program and provides statutory authority for a Medicare payment methodology that applies an add-on payment of up to 3% for new drugs or biologics when the average sales price is unavailable and payment is instead based on the wholesale acquisition cost.
Committee Categories
Business and Industry
Sponsors (10)
Debbie Dingell (D)*,
Michael Burgess (R),
Anna Eshoo (D),
Brett Guthrie (R),
Joseph Kennedy (D),
Frank Pallone (D),
Fred Upton (R),
Tim Walberg (R),
Greg Walden (R),
Peter Welch (D),
Last Action
Became Public Law No: 116-39. (TXT | PDF) (on 08/06/2019)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Loading...